Tumor specific response to photodynamic therapy

S J Stern1, J Craig, S Flock

  • 1University of Arkansas for Medical Sciences, Department of Otolaryngology-Head and Neck Surgery, Phillips Classic Biomedical Laser Research Laboratory, Little Rock 72205.

Insights

Photodynamic therapy (PDT) specifically targets tumors, causing swelling and reduced blood flow. PDT did not affect inert sponges, confirming its tumor-specific effects in this study.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Photochemistry

Background:

  • Photodynamic therapy (PDT) is a cancer treatment, but its precise mechanism of tumor destruction remains unclear.
  • Previous research suggested PDT causes direct cellular damage via reactive oxygen species.
  • Emerging evidence points to PDT's impact on tumor blood flow, raising questions about its specificity to neoplastic tissue.

Purpose of the Study:

  • To investigate the specificity of photodynamic therapy (PDT) effects on tumor tissue versus inert material.
  • To elucidate the mechanism of PDT-induced tumor destruction, focusing on vascular effects and tissue response.

Main Methods:

  • Rats with mammary adenocarcinoma or inert sponge in a window chamber received Photofrin and 630 nm light irradiation.
  • Tumor and chamber dimensions were measured before and after PDT.
  • Histologic analysis was performed 72 hours post-PDT to evaluate tissue response.

Main Results:

  • Tumor-bearing chambers showed significant edema and decreased reflectance, indicating vascular changes.
  • Inert sponge chambers and controls exhibited no edema, demonstrating a lack of non-specific PDT effects.
  • Histologic findings corroborated the observed edema and vascular response in tumor tissues.

Conclusions:

  • Photodynamic therapy (PDT) demonstrates specificity for tumor tissue, inducing localized edema and vascular changes.
  • The observed effects suggest that PDT-mediated tumor destruction involves vascular disruption in addition to direct cellular damage.
  • PDT's targeted action on neoplastic tissue is confirmed, differentiating it from non-specific inflammatory responses.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...